Local excision after preoperative chemoradiation for T2 and T3 rectal cancers: is the wait over?

Affiliations

¹ Department of Surgery, University of Toronto, St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
² Department of Surgery, University of Toronto, St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada. Electronic address: nancy.baxter@unityhealth.to.

Comment

Fahima Dossa et al. Lancet Gastroenterol Hepatol. 2020 May.

. 2020 May;5(5):422-424.

doi: 10.1016/S2468-1253(20)30001-7. Epub 2020 Feb 7.

¹ Department of Surgery, University of Toronto, St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
² Department of Surgery, University of Toronto, St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada. Electronic address: nancy.baxter@unityhealth.to.

No abstract available

Comment on

Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech JJ, Valverde A, de Chaisemartin C, Rivoire M, Trilling B, Jafari M, Portier G, Meunier B, Sieleznieff I, Bertrand M, Marchal F, Dubois A, Pocard M, Rullier A, Smith D, Frulio N, Frison E, Denost Q. Rullier E, et al. Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7. Lancet Gastroenterol Hepatol. 2020. PMID: 32043980 Clinical Trial.